- Home
- ICCC vs LODE Comparison
ICCC vs LODE Comparison
Compare ICCC & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- LODE
- Stock Information
- Founded
- ICCC 1982
- LODE 2008
- Country
- ICCC United States
- LODE United States
- Employees
- ICCC N/A
- LODE N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- LODE Major Chemicals
- Sector
- ICCC Health Care
- LODE Industrials
- Exchange
- ICCC Nasdaq
- LODE Nasdaq
- Market Cap
- ICCC 60.1M
- LODE 53.0M
- IPO Year
- ICCC 1987
- LODE N/A
- Fundamental
- Price
- ICCC $6.71
- LODE $3.73
- Analyst Decision
- ICCC
- LODE Buy
- Analyst Count
- ICCC 0
- LODE 1
- Target Price
- ICCC N/A
- LODE $26.00
- AVG Volume (30 Days)
- ICCC 41.8K
- LODE 535.6K
- Earning Date
- ICCC 08-12-2025
- LODE 08-07-2025
- Dividend Yield
- ICCC N/A
- LODE N/A
- EPS Growth
- ICCC N/A
- LODE N/A
- EPS
- ICCC N/A
- LODE N/A
- Revenue
- ICCC $27,302,766.00
- LODE $3,376,027.00
- Revenue This Year
- ICCC N/A
- LODE $33.58
- Revenue Next Year
- ICCC N/A
- LODE N/A
- P/E Ratio
- ICCC N/A
- LODE N/A
- Revenue Growth
- ICCC 28.29
- LODE 102.20
- 52 Week Low
- ICCC $3.34
- LODE $1.26
- 52 Week High
- ICCC $7.60
- LODE $10.10
- Technical
- Relative Strength Index (RSI)
- ICCC 49.68
- LODE 56.94
- Support Level
- ICCC $5.63
- LODE $3.54
- Resistance Level
- ICCC $7.14
- LODE $3.92
- Average True Range (ATR)
- ICCC 0.64
- LODE 0.28
- MACD
- ICCC -0.06
- LODE -0.04
- Stochastic Oscillator
- ICCC 42.58
- LODE 40.48
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.